ACE2 and pancreatic adenocarcinoma: The mRNA expressions of ACE2 were significantly overexpressed in colon adenocarcinoma, kidney renal papillary cell carcinoma, pancreatic adenocarcinoma, rectum adenocarcinoma (READ) and stomach adenocarcinoma (STAD) (Figures 3a and c and 4a).